Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer? Authors' reply

Affiliations

Editorial

Parambir S Dulai. Aliment Pharmacol Ther. 2020 Apr.

. 2020 Apr;51(7):738-739.

doi: 10.1111/apt.15671.

No abstract available

Comment on

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease.
Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario M, Feagan BG, Bojic D, Trang-Poisson C, Shen B, Altwegg R, Sands BE, Colombel JF, Carbonnel F; GETAID OBSERV-IBD, VICTORY Cohorts Collaboration*. Dulai PS, et al. Aliment Pharmacol Ther. 2020 Mar;51(5):553-564. doi: 10.1111/apt.15609. Epub 2019 Dec 22. Aliment Pharmacol Ther. 2020. PMID: 31867766 Free PMC article.
Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer?
Verstockt B, Ferrante M. Verstockt B, et al. Aliment Pharmacol Ther. 2020 Apr;51(7):737-738. doi: 10.1111/apt.15634. Aliment Pharmacol Ther. 2020. PMID: 32162373 No abstract available.

1. Verstockt B, Ferrante M. Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer? Aliment Pharmacol Ther. 2020; in press.
1. Dulai PS, Boland BS, Singh S, et al. Development and validation of a scoring system to predict outcomes of vedolizumab treatment in patients with Crohn's disease. Gastroenterology. 2018;155(3):687-695 e610.
1. Dulai PS, Amiot A, Peyrin-Biroulet L, et al. A clinical decision support tool may help to optimize vedolizumab therapy in Crohn’s disease. Aliment Pharmacol Ther. 2020;51:553-564.
1. Dulai PS, Singh S, VandeCasteele N, et al. Development and validation of clinical scoring tool to predict treatment outcomes with vedolizumab in ulcerative colitis. Clin Gastroenterol Hepatol; in press.